Review of mifamurtide in the treatment of patients with osteosarcoma.
about
The new deal: a potential role for secreted vesicles in innate immunity and tumor progressionImmunotherapy for Bone and Soft Tissue SarcomasAerosol interleukin-2 induces natural killer cell proliferation in the lung and combination therapy improves the survival of mice with osteosarcoma lung metastasis.Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?Conference report on the 28th annual meeting of the European Musculo-Skeletal Oncology Society, 29 April-1 May 2015, AthensStrategies and developments of immunotherapies in osteosarcomaL-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer.Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression.Sarcoma immunotherapy: past approaches and future directions.Novel insights and therapeutic interventions for pediatric osteosarcoma.Progress and opportunities for immune therapeutics in osteosarcoma.Drugs in early clinical development for the treatment of osteosarcoma.miR-126 inhibits cell growth, invasion, and migration of osteosarcoma cells by downregulating ADAM-9.Monocyte targeting and activation by cationic liposomes formulated with a TLR7 agonist.The HDAC inhibitor Vorinostat diminishes the in vitro metastatic behavior of Osteosarcoma cellsBone sarcomas: from biology to targeted therapies.Managing sarcoma: where have we come from and where are we going?Effects of Arsenic Trioxide on Minor Progressive High-Grade Osteosarcoma of the Extremities Metastatic to the Lung: Results of 39 Patients Treated in a Single Institution.Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.Citrus aurantium Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability.Financial and legislative aspects of drug development of orphan diseases on the European market – a systematic review
P2860
Q28084891-32D94271-89B7-4E50-AF01-1C02B13E3767Q28088363-41F1C2E6-EDB3-4248-AA30-F6B82A425C9EQ34088081-DE7C1909-7B24-4445-8C7D-4E7ADB9227BAQ35653897-96B03BDD-0E24-43DB-B6AA-182EC0DEFF45Q35935343-10EF77DE-29E2-472F-8630-0740DE472443Q36503128-ABE13E03-2AB6-46BA-AA1A-DE0CE84F1516Q36853886-8C1D8EA9-0DFE-42CC-8C12-3E8DF36F7796Q37376512-8F7C793D-CDC0-403C-8904-60041CEF2B24Q38207986-7CAEC31D-725C-439F-AB0A-E4C4E54226A5Q38819276-EA3A575C-2858-4E17-A0BD-68BDCF28526BQ38948905-85101D77-F686-4DFE-8C81-B3FBC2D90472Q38955517-99D37EA0-FDBC-4D41-AEDF-A04626579944Q38957321-FB853F4B-DBF5-4CC2-8990-D5362E7FEAFCQ39038777-E03E2C21-22DA-4C5E-9D77-C7C338A290ADQ41199195-03A2B67C-555C-48DE-BDAE-E43A243E7386Q41923624-0EC750D6-7DE3-4F17-92EA-021AD2B73737Q41988197-D0EB2A44-896B-484A-9681-F9995A815432Q42364914-CB74CD6D-AC95-4B6D-B583-B21FAC1264C4Q50057469-0F70713F-EC9C-4CBC-B550-2BAF893251DDQ55421736-AC6ECBE4-94B9-4007-897B-E442AB0BA327Q58261059-97078996-36A6-4016-83B7-C45D3D66DE48
P2860
Review of mifamurtide in the treatment of patients with osteosarcoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Review of mifamurtide in the treatment of patients with osteosarcoma.
@ast
Review of mifamurtide in the treatment of patients with osteosarcoma.
@en
type
label
Review of mifamurtide in the treatment of patients with osteosarcoma.
@ast
Review of mifamurtide in the treatment of patients with osteosarcoma.
@en
prefLabel
Review of mifamurtide in the treatment of patients with osteosarcoma.
@ast
Review of mifamurtide in the treatment of patients with osteosarcoma.
@en
P2093
P2860
P356
P1476
Review of mifamurtide in the treatment of patients with osteosarcoma.
@en
P2093
Stefan Bielack
Ulrike Pötschger
P2860
P304
P356
10.2147/TCRM.S5688
P577
2010-06-24T00:00:00Z